Arcadia Biosciences
RKDA
14 hedge funds and large institutions have $178K invested in Arcadia Biosciences in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
5.21% less ownership
Funds ownership: 12.5% → 7.29% (-5.2%)
7% less funds holding
Funds holding: 15 → 14 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
59% less capital invested
Capital invested by funds: $431K → $178K (-$253K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$27.1K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.32K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$148K |
| 2 |
VF
Virtu Financial
New York
|
-$34K |
| 3 |
JP Morgan Chase
New York
|
-$1.54K |
| 4 |
Morgan Stanley
New York
|
-$537 |
| 5 |
BlackRock
New York
|
-$119 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $89.1K | -$148K | -57,005 | -59% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $31K | – | – | – |
|
3
State Street
Boston,
Massachusetts
| $26.4K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $23K | +$27.1K | +10,453 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $8.34K | +$2.32K | +894 | +31% |
|
|
6
Morgan Stanley
New York
| $457 | -$537 | -207 | -50% |
|
7
Group One Trading
Chicago,
Illinois
| $39 | – | – | – |
|
8
Wells Fargo
San Francisco,
California
| $20 | – | – | – |
|
9
US Bancorp
Minneapolis,
Minnesota
| $11 | – | – | – |
|
|
OLVIG
10
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| $9 | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $4 | +$5 | +2 | New |
|
|
HI
12
Harbour Investments
Madison,
Wisconsin
| $2 | – | – | – |
|
|
VF
13
Virtu Financial
New York
| – | -$34K | -11,370 | Closed |
|
|
14
JP Morgan Chase
New York
| – | -$1.54K | -508 | Closed |
|
|
15
BlackRock
New York
| – | -$119 | -38 | Closed |
|
RKDA Hedge Fund Activity: Q1 2024 in Review
14 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q1 2024, worth a combined $178K — down 59% from $431K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of RKDA and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $27.1K. The largest seller was Sabby Management, cutting an estimated $148K.
- 14 institutional investors held Arcadia Biosciences (RKDA) as of Q1 2024, down from 15 in Q4 2023.
- Funds reported $178K of Arcadia Biosciences stock for Q1 2024, down 59% quarter-over-quarter.
- 2 funds opened new Arcadia Biosciences positions in Q1 2024 and 3 closed out, a net change of -1 holder.
- The largest Arcadia Biosciences buyer in Q1 2024 was Renaissance Technologies, an estimated $27.1K added.
- The largest Arcadia Biosciences seller in Q1 2024 was Sabby Management, an estimated $148K sold.
Based on aggregated 13F filings for Q1 2024.